New FDA breakthrough-drug category--implications for patients.

Venue / Journal

N Engl J Med

Date

Thu, 07/03/2014 - 12:00

Additional Journal Information

371(1):89-90

Authors

Darrow JJ, Avorn J, Kesselheim AS.

Pubmed URL

http://www.ncbi.nlm.nih.gov/pubmed/24988576